GlassScriptPhysician profile
Alberto Juan Rodriguez
NPI 1316967037
$9,460.22
in general payments reported to CMS, 2019-2025
45 companies · $2,120 in 2025
The $2,120 reported for 2025 was more than what 96% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,626 · 2021: $58.67 · 2022: $1,330 · 2023: $1,864 · 2024: $2,462 · 2025: $2,120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,411 · Long Term Medical Supply Or Device Loan: $29.97 · Education: $4.55.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,411.46 |
| Long Term Medical Supply Or Device Loan | $29.97 |
| Education | $4.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,350.44 | 2021-2025 | Ubrelvy, Vraylar, Qulipta |
| Astrazeneca Pharmaceuticals LP | $1,298.67 | 2019-2025 | Breztri, Bevespi Aerosphere, Airsupra |
| Novo Nordisk INC | $987.56 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Glaxosmithkline, LLC. | $930.39 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Amgen INC. | $750.32 | 2019-2025 | Repatha, Repatha, Otezla |
| Lilly USA, LLC | $668.52 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $389.00 | 2019-2025 | |
| Exact Sciences Corporation | $324.00 | 2023-2025 | Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $293.92 | 2019-2024 | Jardiance |
| Abbott Laboratories | $286.88 | 2019-2025 | Freestyle Libre 3, Freestyle Insulinx |
| Astellas Pharma US INC | $243.20 | 2023-2025 | Veozah |
| Sanofi-Aventis U.S. LLC | $203.09 | 2019-2025 | |
| Ardelyx, INC. | $199.74 | 2024-2025 | Ibsrela |
| Takeda Pharmaceuticals U.S.A., INC. | $189.38 | 2019-2025 | Trintellix, Gattex |
| Janssen Pharmaceuticals, INC | $153.48 | 2019 |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $136.11 | 2025 | Zoryve |
| Bayer Healthcare Pharmaceuticals INC. | $135.61 | 2023 | |
| Romark Laboratories, Lc | $106.68 | 2019 | |
| Merck Sharp & Dohme LLC | $76.10 | 2019-2025 | Capvaxive, Gardasil 9, Vaxneuvance |
| Scilex Pharmaceuticals INC. | $70.60 | 2022-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $68.19 | 2023-2024 | Xifaxan |
| Teleflex LLC | $55.17 | 2022 | |
| Baxter Healthcare | $54.56 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Shield Therapeutics INC | $53.79 | 2024-2025 | |
| Allergan, INC. | $35.84 | 2019 | |
| Amneal Pharmaceuticals LLC | $34.17 | 2025 | Unithroid |
| Radius Health, INC. | $33.71 | 2025 | Tymlos |
| Otsuka America Pharmaceutical, INC. | $28.39 | 2024 | Jynarque |
| Medtronic, INC. | $27.29 | 2022 | |
| Axonics, INC. | $26.82 | 2022 | |
| Horizon Therapeutics Plc | $24.06 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $22.13 | 2025 | Uptravi, Opsumit |
| Intra-Sana Laboratories | $20.17 | 2025 | Reltone 400 Mg, Reltone 200 Mg, Glycate |
| Ironwood Pharmaceuticals, INC | $20.01 | 2023 | Linzess |
| Dexcom, INC. | $19.11 | 2024 | Dexcom G6 Transmitter |
| Lundbeck LLC | $18.87 | 2025 | Rexulti |
| Seqirus USA INC | $18.74 | 2025 | Fluad, Flucelvax |
| Hologic Sales and Service, LLC | $17.87 | 2022 | |
| Indivior INC. | $16.23 | 2019 | |
| Cequr Corporation | $16.00 | 2023 | Cequr Simplicity |
| Daiichi Sankyo INC. | $13.83 | 2019 | |
| Currax Pharmaceuticals LLC | $13.58 | 2024 | Contrave |
| Teva Pharmaceuticals USA, INC. | $10.86 | 2019 | |
| Pfizer Pharmaceuticals LLC | $10.39 | 2019 | |
| Pbg Puerto Rico LLC | $6.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alberto Rodriguez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.